← ConditionsWomen's hormonal & reproductive

Perimenopause / menopause

Two evidence-backed peptide lanes (metabolic, libido); HRT owns vasomotor/bone/sleep.

Decision support, not prescription. You decide.

Primary: Metabolic & Weight ManagementSecondary: Cognitive, Mood & NeuroSecondary: Sexual & Reproductive HealthSecondary: Sleep & CircadianSummary grade: strong
!

MonitorGLP-1 alters oral progesterone absorption

Delayed gastric emptying changes oral progesterone (and other oral drug) absorption/timing — adjust co-prescribing.

Candidate agents

3 agents · ranked by role, then evidence
PT-141 (Bremelanotide)peptide · headlineLeadFDA-approved
Evidence · PubMed
Strong

Bremelanotide FDA-approved for HSDD (premenopausal RCTs); postmenopausal off-label.

PMID 31599840
Community · Reddit
No community reports
Peers · your network
No peer data yet
Semaglutidepeptide · headlineLeadResearch use only

Monitor GLP-1 alters oral progesterone absorption

Evidence · PubMed
Strong

GLP-1 addresses menopausal visceral-fat shift HRT does not; greater loss with HT.

PMID 38446869
Community · Reddit
No community reports
Peers · your network
No peer data yet
Tirzepatidepeptide · headlineResearch use only

Monitor GLP-1 alters oral progesterone absorption

Evidence · PubMed
No evidence rows
Community · Reddit
Positive

6 reports · Peri weight gain + joint pain/inflammation resolved where HRT and PT failed

Peers · your network
No peer data yet

Matching protocol templates

Browse all →

The platform surfaces evidence, community signal and peer outcomes with enforced cautions. It never decides treatment — the licensed clinician orders labs, writes notes, and prescribes.